Down-Regulated NOD2 by Immunosuppressants in Peripheral Blood Cells in Patients with SLE Reduces the Muramyl Dipeptide-Induced IL-10 Production
2011

NOD2 Expression in SLE Patients and Its Regulation by Immunosuppressants

Sample size: 47 publication 10 minutes Evidence: moderate

Author Information

Author(s): Yu Shui-Lian, Wong Chun-Kwok, Wong Purple Tsz-Yan, Chen Da-Peng, Szeto Cheuk-Chun, Li Edmund K., Tam Lai-Shan

Primary Institution: The Chinese University of Hong Kong

Hypothesis

The study investigates the role of NOD2 in the immune response of systemic lupus erythematosus (SLE) patients and how immunosuppressants affect its expression.

Conclusion

Immunosuppressive therapy may downregulate NOD2 expression in SLE patients, which could reduce IL-10 production and affect the regulation of immunopathological mechanisms.

Supporting Evidence

  • NOD2 expression was significantly increased in SLE patients with inactive disease who were not receiving immunosuppressive treatment.
  • Immunosuppressive therapy was associated with decreased NOD2 expression in various immune cells.
  • Basal production of cytokines was significantly increased in immunosuppressant naïve patients compared to healthy controls.

Takeaway

This study shows that a protein called NOD2, which helps the body fight infections, is less active in people with lupus who take certain medicines, which might make them more prone to infections.

Methodology

The study used flow cytometric analysis to assess NOD2 expression in various immune cells from SLE patients and healthy controls, and cytokine production was measured after stimulation with NOD2 agonist.

Potential Biases

Potential bias due to the study's cross-sectional design and the specific population sampled.

Limitations

The study only examined NOD2 function in peripheral blood mononuclear cells and did not explore the effects of immunosuppressants on different cell types in detail.

Participant Demographics

47 female SLE patients of Southern Chinese origin, aged 36±12 years, compared with 31 age- and sex-matched healthy controls.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0023855

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication